Ting Li Net Worth

Ting Li biography

Ting Li is Director of the Company. Ms. Li brings over 20 years of investment banking experience, building relationships between customers and enterprises. Ms. Li is currently a managing partner at Donghai Securities Co., Ltd, a top asset management company inChina, and also serves as the Vice President of the Jilin Enterprise Chamber of Commerce and advisor of the School of Continuing Education of Tsinghua University. Ms. Li holds a bachelor degree in accounting from China's Changchun Taxation College in Changchun, Jilin Province, and a master's degree in software engineering from Jilin University, also in Changchun.

What's Ting Li's mailing address?

Ting's mailing address filed with the SEC is C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746.

Insiders trading at Biostage

Over the last 9 years, insiders at Biostage have traded over $962,849 worth of Biostage stock and bought 1,593,581 units worth $3,804,230 . The most active insiders traders include David Green, Capital Llc Dst und Ronald J Packard. On average, Biostage executives and independent directors trade stock every 79 days with the average trade being worth of $217,604. The most recent stock trade was executed by Capital Llc Dst on 6 April 2023, trading 62,500 units of BSTG stock currently worth $375,000.

What does Biostage do?

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.

Biostage executives and stock owners

Biostage executives and other stock owners filed with the SEC include:

• David Green,
  Director
• Dr. William L. Fodor Ph.D.,
  Chief Scientific Officer
• Yu Hong,
  Pres
• Thomas Robinson,
  Independent Director
• James Shmerling,
  Director
• Ting Li,
  Director
• Harout DerSimonian,
  Chief Scientific Officer
• James Mastridge,
  Interim Vice President - Finance, Principal Financial Officer and Principal Accounting Officer
• Hong Yu,
  President
• Jason Jing Chen,
  Chairman of the Board
• Dr. Shunfu Hu Ph.D.,
  VP of Bus. Devel. & Operations
• Peter A. Pellegrino Jr.,
  Interim VP of Fin.
• David Green,
  CEO & Chairman
• Blaine H. Mc Kee,
  Director
• Saverio La Francesca,
  See Remarks
• John J Canepa,
  Director
• Thomas Mc Naughton,
  Chief Financial Officer
• John F Kennedy,
  Director
• James Joseph Mc Gorry,
  Chief Executive Officer
• William Fodor,
  Chief Scientific Officer
• Herman Sanchez,
  Director
• Xiaoyu Du,
  10% owner
• Matthew D Dallas,
  Director
• Wei Zhang,
  Director
• Jeffrey E Young,
  Director
• Peter M Chakoutis,
  Vice President of Finance
• Ronald J Packard,
  Director
• Capital Llc Dst,
  10% owner
• Jing Chen,
  
• Junli He,
  CEO
• Joseph Luis Jr Damasio,
  Chief Financial Officer